A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin AntibodyShinji Abe, Yasuhiko Nishioka, Yuki Morita et al.|The Journal of Immunology|2013Cited by 91
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibodyWei Wang, Saburo Sone, Yasuhiko Nishioka et al.|Cancer Immunology Immunotherapy|2008Cited by 64
Fibroblast-specific ERK5 deficiency changes tumor vasculature and exacerbates tumor progression in a mouse modelMasaki Imanishi, Keisuke Ishizawa, Yuya Horinouchi et al.|Naunyn-Schmiedeberg s Archives of Pharmacology|2020Cited by 4